We previously showed that the mutation of PLC-δ1 at 864 G to A, accompanied by amino acid replacement of arginine 257 to histidine (R257H), are present in CSA patients, and significantly enhances PLC enzymatic activity in the physiological range of [Ca2+]i [37]. The gene discussed is PLCD1; the disease is chromosome-type aberration frequency.